Physician profile

Brett C Hill

Urology · Omaha, NE

NPI 1649498403

$10,580.06

in general payments reported to CMS, 2019-2025

47 companies · $1,694 in 2025

The $1,694 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,780.73
Travel and Lodging$597.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Neotract INC. $2,745.84 2019-2020
Axonics, INC. $1,507.59 2020-2023 Axonics
Teleflex LLC $1,326.81 2021-2025 Barrigel, Urolift
Boston Scientific Corporation $523.05 2019-2025 Ams 700, Lux-Dx Insertable Cardiac Monitor, General - Erectile Dysfunction
Smith+Nephew, INC. $508.52 2023-2025 Stravix, Stravix Pl, Oasis
Agiliti Surgical, INC. $312.39 2025 Sonablate Hifu, Koelis Trinity Mri/US Fusion
Sumitomo Pharma America, INC. $274.67 2023-2025 Orgovyx, Gemtesa
Urogen Pharma, INC. $265.97 2024-2025
Endo Pharmaceuticals INC. $221.83 2019-2023 Aveed, Xiaflex
Myovant Sciences INC. $195.58 2021-2022
Intuitive Surgical, INC. $186.83 2019-2021
Davol INC. $181.67 2020-2021
Karl Storz Endoscopy-America $146.37 2019-2020
Dendreon Pharmaceuticals LLC $146.17 2021-2025 Provenge
Galvanize Therapeutics, INC $139.31 2025 Aliya System
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Acumed LLC $137.80 2023 Acumed
Ethicon US, LLC $125.00 2022
Procept Biorobotics Corporation $124.99 2025
Abbvie INC. $124.75 2019-2025
Tela Bio, INC. $115.50 2022
Antares Pharma, INC. $106.95 2019-2022
Verity Pharmaceuticals INC. $95.83 2022-2023 Trelstar
Srs Medical Systems, INC. $84.14 2021
Tolmar, INC. $83.47 2023-2024
Bayer Healthcare Pharmaceuticals INC. $80.35 2023-2025
Janssen Biotech, INC. $79.50 2022-2025 Erleada, Akeega
Edap Technomed INC $78.00 2024
Accord Healthcare, INC. $77.51 2022-2023
Merck Sharp & Dohme LLC $63.32 2022-2025 Keytruda
Pfizer INC. $58.59 2019-2025
180 Medical, INC. $51.19 2019-2021
Calyxo, INC. $48.43 2025 Cvac Aspiration System
Ferring Pharmaceuticals INC. $48.06 2019-2025 Adstiladrin
Urovant Sciences INC $36.53 2022
Astellas Pharma US INC $35.30 2019-2021
Blue Earth Diagnostics $33.97 2022-2024
Janssen Scientific Affairs, LLC $33.91 2019
Sun Pharmaceutical Industries INC. $32.87 2024-2025
Telix Pharmaceuticals $20.82 2025 Illuccix
E.R. Squibb & Sons, L.L.C. $17.50 2022
Laborie Medical Technologies Corp. $16.75 2024 Urgent PC Neuromodulation System
Coloplast Corp $16.38 2021
Amgen INC. $14.64 2022
Cook Medical LLC $14.47 2025 Resonance
Novartis Pharmaceuticals Corporation $13.98 2023
Astrazeneca Pharmaceuticals LP $13.64 2022
Allergan, INC. $13.32 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brett C Hill

$10,580.06

in general payments reported 2019-2025

Years
2019-2025
Top company
Neotract INC.
Context
The $1,694 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/723824/brett-c-hill

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.